About the Journal
The Journal of Precision Molecular and Clinical Oncology (JPMCO) is an international, peer-reviewed scholarly journal dedicated to the publication of high-quality research that advances the understanding and clinical application of precision medicine in oncology. The journal provides a trusted platform for the dissemination of innovative scientific findings, emerging technologies, and evidence-based clinical practices that contribute to the prevention, diagnosis, and treatment of cancer.
JPMCO is committed to promoting excellence in scientific publishing by maintaining rigorous editorial standards, a fair and transparent peer-review process, and adherence to recognized ethical publishing practices. The journal welcomes contributions from researchers, clinicians, academicians, healthcare professionals, and industry experts who are engaged in advancing cancer research and patient care.
Through its open-access publishing model, JPMCO ensures that published research is freely accessible to readers worldwide, facilitating the rapid exchange of knowledge and supporting global scientific collaboration. The journal seeks to foster interdisciplinary communication between basic scientists, translational researchers, and clinical practitioners, helping to bridge the gap between laboratory discoveries and their application in clinical settings.
JOURNAL INFORMATION
- Publisher: SciTxtHub
- Publication Model: Gold Open Access
- Peer Review Model: Double-Blind Peer Review
- Publication Frequency: Biannual (Two Issues per Year)
- Language of Publication: English
